Feedback / Questions
AV-1959R - Nuravax
https://www.prnewswire.com/news-releases/nuravax-institute-for-molecular-medicine-to-present-phase-1-results-and-phase-2-design-of-alzheimers-vaccine-av-1959r-at-ctad-2025-302495153.html
Jul 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next